Fludarabine Phosphate (Teva Parenteral Medicines, Inc.)


Welcome to the PulseAid listing for the Fludarabine Phosphate drug offered from Teva Parenteral Medicines, Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Teva Parenteral Medicines, Inc.
NON-PROPRIETARY NAME: Fludarabine Phosphate
SUBSTANCE NAME: FLUDARABINE PHOSPHATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2003-09-12
END MARKETING DATE: 2018-12-31


Fludarabine Phosphate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFludarabine Phosphate from Teva Parenteral Medicines, Inc.
LABELER NAME: Teva Parenteral Medicines, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/2mL)
START MARKETING DATE: 2003-09-12
END MARKETING DATE: 2018-12-31
PRODUCT ID: 0703-5854_e138bb88-2459-440d-ac50-fbb561c4b4b3
PRODUCT NDC: 0703-5854
APPLICATION NUMBER: ANDA076349

Other FLUDARABINE PHOSPHATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Fludarabine phosphate
APP Pharmaceuticals, LLCFludarabine
Fresenius Kabi USA, LLCFludarabine
Hospira, Inc.Fludarabine Phosphate
Mylan Institutional LLCFludarabine Phosphate
Pfizer Laboratories Div Pfizer Inc.Fludarabine Phosphate
Sagent PharmaceuticalsFludarabine Phosphate
Sandoz IncFludarabine Phosphate
Teva Parenteral Medicines, Inc.Fludarabine Phosphate